Building A Future-Ready MarTech Strategy at the MarketsandMarkets MarTech Innovation & Leadership Summit – A combination of Artificial Intelligence, Machine Learning, Big Data and Customer Experience

Building A Future-Ready MarTech Strategy at the MarketsandMarkets MarTech Innovation & Leadership Summit – A combination of Artificial Intelligence, Machine Learning, Big Data and Customer Experience

London, United Kingdom, 15th January – The MarketsandMarkets MarTech Innovation & Leadership Summit scheduled to be held on 26th – 27th March 2020 in London -UK will host Industry Giants such as HubSpot, Google, BNY Mellon, Tata Global Beverages, Microsoft, IBM iX, Oracle, eBAY, HCL Technologies, Adidas, Hewlett Packard Enterprise​ to present their most recent innovations, new marketing strategies and technologies which will give our attendees a complete understanding about the marketing landscape in 2020. The Summit will gather 35+ leading industry speakers and 150+ professionals. The 2-day event will…

Read More

Speaker Interview with Francesco Orlandino for the MarketsandMarkets MarTech Innovation & Leadership Summit

Speaker Interview with Francesco Orlandino for the MarketsandMarkets MarTech Innovation & Leadership Summit

Francesco Orlandino is a Digital, eCommerce and Brand Marketing professional with over 10 years in global brands: during this time, he has had the chance of living in 5 different countries across Europe and the Americas. His experience sits mostly within Business-to-Consumer, having worked mostly in Retail, Fashion and FMCG. For 7 years he has been developing my career within Adidas, in Global, regional and local roles within the Digital and eCommerce Function. My expertise spans across several digital-disciplines: Performance Marketing, Consumer Engagement, Digital Planning and Transformation. He is a…

Read More

Liliana Caimacan talks about ‘Building strong brands through Purpose’ at the MarketsandMarkets MarTech Innovation & Leadership Summit

Liliana Caimacan talks about ‘Building strong brands through Purpose’ at the MarketsandMarkets MarTech Innovation & Leadership Summit

An experienced, international business leader, Liliana has been leading transformational growth across brands and portfolios to drive step changes in business results for over 20 years. She is a leading expert on innovation, communication and business strategy within the FMCG and luxury industries, working with top blue-chip companies: Unilever, Tata, on world-class brands and portfolios. Her sector experience covers Consumer Goods, Personal Care, Home Care, Foods, Refreshments, and Luxury, as well as driving disruptive innovations projects. She holds a Master’s in Marketing & Communications and an Executive MBA. With extensive…

Read More

Florian Bonnet talks about ‘Behavioral Personalization’ at the MarketsandMarkets MarTech Innovation & Leadership Summit

Florian Bonnet talks about ‘Behavioral Personalization’ at the MarketsandMarkets MarTech Innovation & Leadership Summit

London, January 10 – Florian Bonnet is a Head of Product at Zizoo, named one of Forbes’ top ‘Travel Tech Startups Taking Europe by Storm’. Zizoo is bringing boat holidays to the mass market, offering over 23,000 boat experience products across 500+ destinations worldwide. In his position, he is responsible for all the Digital Product and Data activities. Prior to that, he held several positions at HelloFresh, the leading meal kit company and global provider of fresh food at home, where he led the Conversion Tribe as a Sr. Director…

Read More

Speaker Interview with Fabio D’Agostino for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

Speaker Interview with Fabio D’Agostino for 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress

London, January 07 – MarketsandMarkets interviewed Fabio D’Agostino,Venture Partner, Claris Ventures regarding 4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies & Regenerative Medicine Congress taking place on 10-11 March 2020 in London – UK.   Q. What is the most trending areas of cellular therapies currently? ​ A. CART and NK cell Q. What are the recent developments and technological advancements?  A. CART for solid tumors and NK CAR  Q. What are the key take away points from your presentation? ​ A. They are basically summarized in my bullet points. I will…

Read More

Amber Donahue speaks about Business Fit-for-Purpose: From Sample Management to Validation to Final Sample Analysis Data at the 5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

Amber Donahue speaks about Business Fit-for-Purpose: From Sample Management to Validation to Final Sample Analysis Data at the 5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

Amber Donahue, Ph.D. is a Senior Manager, Biomarker Clinical Assay Lead in the Oncology Clinical Assay Group in Global Product Development at Pfizer. She is responsible for scientific technical oversight and operational management of external and internal partners performing clinical trial biomarker sample analyses aligned with translational oncology strategies. Prior to joining Pfizer in early 2015, she developed and validated esoteric testing assays for the Hematology/Oncology R&D group at Quest Diagnostics-San Juan Capistrano. Amber holds a Ph.D. in Molecular Biology & Biochemistry, with a focus in Immunology, from the University…

Read More

Jason Christiansen speaks about Targeting extrachromosomal DNA (ecDNA), a new approach to treating cancers with high copy number gene amplification at the 5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

Jason Christiansen speaks about Targeting extrachromosomal DNA (ecDNA), a new approach to treating cancers with high copy number gene amplification at the 5th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference

Jason Christiansen, Chief Technology Officer for Boundless Bio has served in multiple leadership positions overseeing the development of new technologies and strategies for, research, diagnostic use, and targeted therapy development. He has served as Head of Assay Development at Roche Sequencing Solutions, providing leadership in initiatives around oncology testing, Dx development, NIPT testing and platform development. Prior to Roche, Jason was VP of Diagnostics at Ignyta, where he led CDx development efforts including an in house CLIA laboratory and molecular testing R&D group working both internally and externally to drive…

Read More

What do MNM Analysts have to say about the Immuno Oncology Market?

What do MNM Analysts have to say about the Immuno Oncology Market?

Our 4th Annual MarketsandMarkets Next Gen Immuno-Oncology Congress to be held on 12th-13th March 2020 in London, UK would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes, pharmaceutical, bio-pharmaceutical, and biotechnology companies to discuss the latest updates in the development of ADC’s, Bispecific Antibodies, Cellular Therapy, and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccines development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case…

Read More

BMS, Takeda, Celgene, Boehringer-Ingelheim & Biogen will Speak at 2nd Annual MarketsandMarkets Real-World Data & Life Science Analytics Congress

BMS, Takeda, Celgene, Boehringer-Ingelheim & Biogen will Speak at 2nd Annual MarketsandMarkets Real-World Data & Life Science Analytics Congress

Boston, USA, 5th September – 2nd Annual MarketsandMarkets Real-World Data & Life Science Analytics Congress will be hosting industry giants like Bristol Myers Squibb, Takeda, Genentech, Boehringer-Ingelheim, Celgene and Biogen will take place at the DoubleTree by Hilton Boston-Downtown on 25th & 26th October 2019. Presenting 20+ RWD case studies, the congress aims to discuss accelerating the adoption of Real-world Evidence, capabilities of newer technologies for evidence generation within the industry. The event agenda will focus on key aspects such as Real-World Evidence Methodologies, FDA’ strategic framework, Applications of Artificial Intelligence…

Read More

Technologies Transforming Real-World Evidence (RWE) Evidence in the Pharmaceutical Industry

Technologies Transforming Real-World Evidence (RWE) Evidence in the Pharmaceutical Industry

As new drugs are emerging every day, it is very important to ensure that the patients get right and effective treatment. One such step can be taken from Real World Evidence (RWE). In simple words, Real World Evidence means data and information collected outside of a clinical trial. This data can be electronic medical records, medical charts or other medical claims to assess patient outcomes. It is made sure that the patient’s identity is removed from the previous data to maintain the patient’s privacy. However, today’s real-world evidence data is…

Read More